CDR2 antigen and Yo antibodies (Q34507995)

2 August 2017

title

CDR2 antigen and Yo antibodies (English)

1 reference

2 August 2017

1 reference

Bjørn I Haukanes

9

0 references

Christian A Vedeler

10

object named as

Christian A Vedeler

1 reference

2 August 2017

8

Sverre Mørk

1 reference

2 August 2017

Cecilie Totland

1

1 reference

2 August 2017

Nina K Aarskog

2

1 reference

2 August 2017

Tilo W Eichler

3

1 reference

2 August 2017

Mette Haugen

4

1 reference

2 August 2017

Jane K Nøstbakken

5

1 reference

2 August 2017

Sissel E Monstad

6

1 reference

2 August 2017

Helga B Salvesen

7

1 reference

2 August 2017

publication date

16 November 2010

1 reference

Cancer Immunology, Immunotherapy

2 August 2017

published in

1 reference

2 August 2017

volume

60

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

283-289

1 reference

The onconeural antigen cdr2 is a novel APC/C target that acts in mitosis to regulate c-myc target genes in mammalian tumor cells

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3024499

Antibody to CCDC104 is associated with a paraneoplastic antibody to CDR2 (anti-Yo).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3024499

Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3024499

Paraneoplastic neurological syndromes and onconeural antibodies: clinical and immunological aspects.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3024499

Proteasome antibodies in paraneoplastic cerebellar degeneration

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3024499

Paraneoplastic Syndromes Involving the Nervous System

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3024499

Interaction of a paraneoplastic cerebellar degeneration-associated neuronal protein with the nuclear helix-loop-helix leucine zipper protein MRG X

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3024499

The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: implications for neuronal and tumor cell survival

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3024499

PKN Interacts with a Paraneoplastic Cerebellar Degeneration-Associated Antigen, Which Is a Potential Transcription Factor

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3024499

Differential expression of the neuroendocrine genesHel-N1 andHuD in small-cell lung carcinoma: Evidence for down-regulation ofHuD in the variant phenotype

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3024499

A post-transcriptional regulatory mechanism restricts expression of the paraneoplastic cerebellar degeneration antigen cdr2 to immune privileged tissues

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3024499

Effect of a paraneoplastic cerebellar degeneration-associated neural protein on B-myb promoter activity

7 July 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-010-0943-9

Morphological and immunohistochemical characterization of paraneoplastic cerebellar degeneration associated with Yo antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-010-0943-9

Onconeural antibodies in sera from patients with various types of tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-010-0943-9

Molecular analysis of the HuD gene in neuroendocrine lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-010-0943-9

Regulatory T cells in paraneoplastic neurological syndromes

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3024499

Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer

27 October 2018

1 reference

12 December 2020

Yo antibodies in ovarian and breast cancer patients detected by a sensitive immunoprecipitation technique

1 reference

12 December 2020

HLA-DQ2 individuals are susceptible to Hu-Ab associated paraneoplastic neurological syndromes

1 reference

12 December 2020

Cdr2, a target antigen of naturally occuring human tumor immunity, is widely expressed in gynecological tumors

1 reference

12 December 2020

10.1007/S00262-010-0943-9

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference

2 August 2017

1 reference